Claritev Corporation (CTEV) - Total Liabilities
Based on the latest financial reports, Claritev Corporation (CTEV) has total liabilities worth $5.06 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Claritev Corporation (CTEV) cash flow conversion to assess how effectively this company generates cash.
Claritev Corporation - Total Liabilities Trend (2019–2025)
This chart illustrates how Claritev Corporation's total liabilities have evolved over time, based on quarterly financial data. See Claritev Corporation book value and equity for net asset value and shareholders' equity analysis.
Claritev Corporation Competitors by Total Liabilities
The table below lists competitors of Claritev Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wiz Soluções e Corretagem de Seguros S.A
SA:WIZC3
|
Brazil | R$1.11 Billion |
|
Beyond Meat Inc
NASDAQ:BYND
|
USA | $540.83 Million |
|
Spirox Corp
TW:3055
|
Taiwan | NT$307.69 Million |
|
Tyro Payments Ltd
AU:TYR
|
Australia | AU$320.74 Million |
|
CARYSIL LIMITED
NSE:CARYSIL
|
India | Rs4.74 Billion |
|
Iochpe-Maxion S.A
SA:MYPK3
|
Brazil | R$9.78 Billion |
|
UTKARSH SMALL FINANCE BANK ORD (BSE)
NSE:UTKARSHBNK
|
India | Rs249.90 Billion |
|
Nexpoint Real Estate Finance Inc
NYSE:NREF
|
USA | $4.49 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Claritev Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Claritev Corporation market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -29.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Claritev Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Claritev Corporation (2019–2025)
The table below shows the annual total liabilities of Claritev Corporation from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $5.06 Billion | -0.22% |
| 2024-12-31 | $5.07 Billion | -3.59% |
| 2023-12-31 | $5.26 Billion | -5.82% |
| 2022-12-31 | $5.58 Billion | -5.02% |
| 2021-12-31 | $5.88 Billion | +2.62% |
| 2020-12-31 | $5.73 Billion | -10.19% |
| 2019-12-31 | $6.38 Billion | -- |
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary n… Read more